Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The burden and the challenge of treatment-resistant depression
Charalampos Touloumis
Psychiatriki (2021) Vol. 32, Iss. Supplement 1, pp. 11-14
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

SCFAs Supplementation Rescues Anxiety- and Depression-like Phenotypes Generated by Fecal Engraftment of Treatment-Resistant Depression Rats
Mani Surya Kumar Palepu, Siva Nageswara Rao Gajula, K. Malleshwari, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 5, pp. 1010-1025
Closed Access | Times Cited: 15
The therapeutic effects of saikosaponins on depression through the modulation of neuroplasticity: From molecular mechanisms to potential clinical applications
Chen Shen, Ke Wang, Hongzhan Wang, et al.
Pharmacological Research (2024) Vol. 201, pp. 107090-107090
Open Access | Times Cited: 11
Short-term and long-term efficacy of accelerated transcranial magnetic stimulation for depression: a systematic review and meta-analysis
Ruifeng Shi, Zuxing Wang, Dong Yang, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systematic review and network meta-analysis
Itsuki Terao, Takahiro Tsuge, Kaori Endo, et al.
Journal of Affective Disorders (2023) Vol. 346, pp. 49-56
Closed Access | Times Cited: 15
Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review
Octavian Vasiliu
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 411-411
Open Access | Times Cited: 13
Lactate: a prospective target for therapeutic intervention in psychiatric disease
Yanhui Cai, Haiyun Guo, Tianle Han, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 7, pp. 1473-1479
Open Access | Times Cited: 13
HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression
Xiao Huang, Bo Wang, Jing Yang, et al.
Brain Behavior & Immunity - Health (2023) Vol. 30, pp. 100641-100641
Open Access | Times Cited: 12
EEG alpha activity as predictor for TBS-rTMS treatment outcome in Depression
Barbora Provaznikova, Anna Monn, Erich Seifritz, et al.
Journal of Psychiatric Research (2025) Vol. 182, pp. 4-12
Closed Access
An Analysis of Primary Hyperparathyroidism in Association with Depression or Anxiety
Ana-Maria Gheorghe, Claudiu Nistor, Aurelian Emil Ranetti, et al.
Diseases (2025) Vol. 13, Iss. 2, pp. 54-54
Open Access
The Role of Acupuncture of 13 Ghost Points Combined with Cognitive Therapy in Alleviating Liver-qi Stagnation Depression: A Clinical Study
Xiaojian Yin, Xiaoyang Wang
Journal of physiological investigation. (2025)
Open Access
Higher levels of total cholesterol/high-density lipoprotein cholesterol ratios are associated with an increased risk of suicidal behavior in children and adolescents with depressive disorders
Nana Sun, Zhiwei Liu, Liang Sun, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Affective bias predicts changes in depression during deep brain stimulation therapy
Brian Cui, Madaline Mocchi, Brian Metzger, et al.
Frontiers in Human Neuroscience (2025) Vol. 19
Open Access
Advances in the Study of NMDA Receptors in Depression Pathogenesis and the Antidepressant Efficacy of Their Antagonists
Mingrui Chen, Jingyan Jin, Hongsheng Bi, et al.
Asian Journal of Psychiatry (2025), pp. 104502-104502
Closed Access
The impact of psychiatric comorbidities associated with depression: a literature review
Rita Ioana Platona, Georgiana Albina Căiță, Florica Voiţă-Mekereş, et al.
Medicine and Pharmacy Reports (2024) Vol. 97, Iss. 2, pp. 143-148
Open Access | Times Cited: 3
Effects of exercise therapy on anxiety and depression in patients with COVID-19: a systematic review and meta-analysis
Ju Tang, Liang‐Liang Chen, Hongtao Zhang, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 3
Association of volatile organic compounds exposure with the risk of depression in U.S. adults: a cross‑sectional study from NHANES 2013–2016
Yue Zhu, Yinghui Ju, Menglin Wang, et al.
International Archives of Occupational and Environmental Health (2023) Vol. 96, Iss. 8, pp. 1101-1111
Closed Access | Times Cited: 8
The rapid antidepressant effect of acupuncture on two animal models of depression by inhibiting M1-Ach receptors regulates synaptic plasticity in the prefrontal cortex
Baile Ning, Zhifang Wang, Jiangshan He, et al.
Brain Research (2023) Vol. 1822, pp. 148609-148609
Closed Access | Times Cited: 8
Exosomes may be the carrier of acupuncture treatment for major depressive disorder
Qin Lyu, Xin Zhou, Liuqing Shi, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Magnetic Waves vs. Electric Shocks: A Non-Inferiority Study of Magnetic Seizure Therapy and Electroconvulsive Therapy in Treatment-Resistant Depression
Helena Bellini, Eric Cretaz, Adriana Munhoz Carneiro, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2150-2150
Open Access | Times Cited: 7
Protocol of a prospective community-based study about the onset and course of depression in a nationally representative cohort of adults in China: the China Depression Cohort Study-I
Xuting Li, Yusheng Tian, Michael R. Phillips, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Lycopene alleviates BCG-induced depressive phenotypes in mice by disrupting 5-HT3 receptor – IDO1 interplay in the brain
Rucha S. Deore, R.A. Ansari, Sanjay N. Awathale, et al.
European Journal of Pharmacology (2024) Vol. 977, pp. 176707-176707
Closed Access | Times Cited: 2
Prevalence and clinical correlates of thyroid dysfunction in first-episode and drug-naïve major depressive disorder patients with metabolic syndrome
Quanfeng Zhu, Guojun Jiang, Xiaoe Lang, et al.
Journal of Affective Disorders (2023) Vol. 341, pp. 35-41
Closed Access | Times Cited: 6
Prevalence and correlates of dyslipidemia in first-episode and drug-naïve major depressive disorder patients with comorbid abnormal glucose metabolism: Sex differences
Quanfeng Zhu, Yali Zheng, Xiaoe Lang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5
Changes in Adipokine, Resitin, and BDNF Concentrations in Treatment-Resistant Depression after Electroconvulsive Therapy
Agnieszka Permoda‐Osip, Magda Malewska-Kasprzak, Maria Skibińska, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1358-1358
Open Access | Times Cited: 5
Electroconvulsive Therapy for Treatment-Resistant Depression: Dispelling the Stigma
Deborah Salani, Deana Goldin, Beatriz Valdes, et al.
Journal of Psychosocial Nursing and Mental Health Services (2023) Vol. 61, Iss. 6, pp. 11-17
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top